Additionally, a selective IGF1R kinase inhibitor exhibited antitumor effects in adult and pediatric adrenocortical tumor cell lines, suggesting that IGF1R inhibitors represent a promising therapy for human adrenocortical carcinoma [10]. The gene discussed is IGF1R; the disease is adrenal cortex carcinoma.